Enhanced T Cell Migration to Sites of Microscopic CNS Disease: Complementary Treatments Evaluated by 2‐ and 3‐D Image Analysis

Lois A. Lampson, Anthony Chen, Alexander O. Vortmeyer, Andrew E. Sloan, Zoher Ghogawala, Lorence Kim

Research output: Contribution to journalArticle

14 Scopus citations

Abstract

Novel therapies are being developed to attack tumour or other abnormal cells within the brain. A general problem is the need for delivery to sites of microscopic disease. Leukocytes offer an attractive solution; they are able to both move through tissue and recognize abnormal targets. Leukocytes may act as effectors, or as vehicles for drugs, retroviral vectors or other agents. Here, we illustrate complementary ways of enhancing leukocyte migration to sites of microscopic central nervous system (CNS) disease. Enhanced T cell migration to sites of disseminated tumour is used as the example. Computer‐assisted image analysis is used to evaluate migration patterns in 2 and 3 dimensions. Shared regulatory features in the migration of tumour and responding cells, and the opportunities and questions they imply, are discussed.

Original languageEnglish (US)
Pages (from-to)125-134
Number of pages10
JournalBrain Pathology
Volume4
Issue number2
DOIs
StatePublished - Apr 1994
Externally publishedYes

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Neuroscience(all)
  • Clinical Neurology

Fingerprint Dive into the research topics of 'Enhanced T Cell Migration to Sites of Microscopic CNS Disease: Complementary Treatments Evaluated by 2‐ and 3‐D Image Analysis'. Together they form a unique fingerprint.

  • Cite this